HealthMap, a team of researchers, epidemiologists and software developers at Boston Children's Hospital founded in 2006, is an established global leader in utilizing online informal sources for disease outbreak monitoring and real-time surveillance of emerging public health threats.
These therapies are effective for treating mild to moderate migraine pain. Specific acute care medications include dihydroergotamine (DHE) and the triptans (sumatriptan, rizatriptan, zolmitriptan, naratriptan, eletriptan, and frovatriptan).These medications both inhibit dilatation of meningeal vessels and reduce abnormal neural activation.he half-life of most of the available medications is approximately 2 to 3 hours; those with longer half-lives (eg, DHE nasal spray, naratriptan, eletriptan, and frovatriptan) have lower recurrence rates (15% to 20% vs 30% for other triptans). Recurrence with triptans tends to occur within 8 to 12 hours.
They may not work for atypical or unusually severe migraine attacks, transformed migraine, or status (continuous) migrainosus. Triptans are highly effective, reducing the symptoms or aborting the attack within 30 to 90 minutes in 70-80% of patients.riptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches. They were first introduced in the 1990s. While effective at treating individual headaches, they do not provide preventative treatment and are not considered a cure.